Hello and Welcome to Patientsville.com, Your Source for all KENTERA information. We are dedicated to provide You with KENTERA safety information. Learn about KENTERA serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
KENTERA Safety Reports
Total KENTERA reports: 10.KENTERA FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 3.
Take KENTERA Side Effects Survey or Share Your KENTERA Story. Read More Here.
Consumer or non-health professional from UNITED KINGDOM reported KENTERA problem on Feb 27, 2007. Female patient, 68 years of age, weighting 188.9 lb, was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: epistaxis, retinal haemorrhage. KENTERA dosage: 3.9 MG, DAILY, TRANSDERMAL. During the same period patient was treated with METHENAMINE, ATORVASTATIN CALCIUM, BENDROFLUAZIDE, TRIMETHOPRIM. Patient recovered.
KENTERA problem was reported by a Pharmacist from UNITED KINGDOM on July 05, 2006. Male patient, 95 years of age, was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, confusional state, head injury. KENTERA dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, RAMIPRIL, ASPIRIN, IMOUR, METFORMIN, CLICLAZIDE, LORAZEPAM. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported KENTERA problem on June 29, 2006. Female patient, 84 years of age, weighting 134.5 lb, was diagnosed with urge incontinence, hypertension, cerebral disorder and was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, transient ischaemic attack. KENTERA dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, GODAMED TAH. Patient was hospitalized. Patient recovered.
KENTERA problem was reported by a Physician from GERMANY on July 03, 2006. Female patient, 68 years of age, weighting 147.7 lb, was diagnosed with urge incontinence and was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic coma. KENTERA dosage: unknown. During the same period patient was treated with AMARYL, MELOXICAM, ENALAPRIL MALEATE, ALENDRONAT, NITROXOLIN. Patient recovered.
Physician from GERMANY reported KENTERA problem on July 04, 2006. Male patient, 76 years of age, weighting 180.8 lb, was diagnosed with urge incontinence and was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. KENTERA dosage: unknown. During the same period patient was treated with PREDNISOLONE, SYMBICORT, SPIRIVA, ACETYLSALICYLIC ACID SRT, ENALAPRIL MALEATE. Patient died.
KENTERA problem was reported by a Physician from GERMANY on July 21, 2006. Female patient, 68 years of age, weighting 147.7 lb, was diagnosed with urge incontinence and was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic coma. KENTERA dosage: unknown. During the same period patient was treated with AMARYL, MELOXICAM, ENALAPRIL MALEATE, ALENDRONAT, NITROXOLIN. Patient recovered.
Physician from GERMANY reported KENTERA problem on Aug 15, 2006. Male patient, 76 years of age, weighting 180.8 lb, was diagnosed with urge incontinence and was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: cardiac failure, coronary artery disease. KENTERA dosage: unknown. During the same period patient was treated with PREDNISOLONE, SYMBICORT, SPIRIVA, ACETYLSALICYLIC ACID, ENALAPRIL. Patient died.
KENTERA problem was reported by a Physician from GERMANY on Oct 30, 2006. Female patient, 90 years of age, was diagnosed with incontinence and was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: aortic stenosis, cardiac failure. KENTERA dosage: unknown. During the same period patient was treated with FURESE, ENALAPRIL MALEATE. Patient died.
Physician from GERMANY reported KENTERA problem on Oct 27, 2006. Female patient, 92 years of age, weighting 112.4 lb, was diagnosed with urge incontinence and was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, malignant neoplasm progression. KENTERA dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, TORSEMIDE, METOHEXAL, GLUCOBAY, ASPIRIN. Patient was hospitalized. Patient died on 08/28/2006.
KENTERA problem was reported by a Physician from FINLAND on Aug 16, 2007. Female patient, 74 years of age, was treated with KENTERA. After drug was administered, patient experienced the following problems/side effects: hallucination, visual. KENTERA dosage: 3.9 MG, DAILY, TRANSDERMAL. During the same period patient was treated with STALEVO, ELDEPRYL, SIFROL, RENITEC. Patient recovered.